文献速递细菌感染、耐药与抗菌药物医院感染防控

MRSA基因组监测成本效果的早期数学模型研究

Genomic Surveillance of Methicillin-resistant Staphylococcus aureus: A Mathematical Early Modeling Study of Cost-effectiveness.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该英国成本效果研究基于NHS与个人社会服务视角构建早期模型,比较全基因组测序加现行实践与单独现行实践。结论认为主动基因组监测可能具成本效果,需前瞻性研究进一步评估。

要点

  • 主动MRSA基因组监测在模型中可能节省成本并减少传播。
  • 效果假设为MRSA获得减少90%时,避免290例病例和2例死亡。
  • 结果对住院期间MRSA阴性患者获得MRSA的概率最敏感。

核心结论

  • 主动MRSA基因组监测可能具成本效果,但需前瞻性研究进一步评估。

研究设计与样本

  • 英国成本效果研究,基于NHS与个人社会服务视角构建早期模型,比较全基因组测序加现行实践与单独现行实践。
  • 效果基于住院患者索引入院后一年内总MRSA获得相对减少,并做敏感性分析。

主要发现

  • 假设测序使MRSA获得减少90%,避免290例新发MRSA病例,绝对减少28.8%,避免2例MRSA相关死亡。
  • 总QALY影响较温和,测序带来额外14.28个QALY。
  • 结果对MRSA阴性患者住院期间获得MRSA的概率变化最敏感。

临床怎么用

  • 在模型中,主动基因组监测可指导早期且高度靶向的感染控制干预以阻断传播。
  • 临床决策需结合本地MRSA获得风险,因模型结果对该概率最敏感。

局限性

  • 为早期数学模型研究,非前瞻性研究,结论需前瞻性研究验证。
  • 效果基于假设的90%MRSA获得减少,非实测干预效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genomic surveillance of methicillin-resistant Staphylococcus aureus (MRSA) identifies unsuspected transmission events and outbreaks. Used proactively, this could direct early and highly targeted infection control interventions to prevent ongoing spread. Here, we evaluated the cost-effectiveness of this intervention in a model that compared whole-genome sequencing plus current practice versus current practice alone. METHODS: A UK cost-effectiveness study was conducted using an early model built from the perspective of the National Health Service and personal social services. The effectiveness of sequencing was based on the relative reduction in total MRSA acquisitions in a cohort of hospitalized patients in the year following their index admissions. A sensitivity analysis was used to illustrate and assess the level of confidence associated with the conclusions of our economic evaluation. RESULTS: A cohort of 65 000 patients were run through the model. Assuming that sequencing would result in a 90% reduction in MRSA acquisition, 290 new MRSA cases were avoided. This gave an absolute reduction of 28.8% and avoidance of 2 MRSA-related deaths. Base case results indicated that the use of routine, proactive MRSA sequencing would be associated with estimated cost savings of over £728 290 per annual hospitalized cohort. The impact in total quality-adjusted life years (QALYs) was relatively modest, with sequencing leading to an additional 14.28 QALYs gained. Results were most sensitive to changes in the probability of a MRSA-negative patient acquiring MRSA during their hospital admission. CONCLUSIONS: We showed that proactive genomic surveillance of MRSA is likely to be cost-effective. Further evaluation is required in the context of a prospective study.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dymond A, Davies H, Mealing S, et al. Genomic Surveillance of Methicillin-resistant Staphylococcus aureus: A Mathematical Early Modeling Study of Cost-effectiveness. Clin Infect Dis. 2020. PMID: 31219153. doi:10.1093/cid/ciz480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。